Recently, endocan has been identified to be overexpressed at the messenger RNA and/or protein levels in several tumor types, including glioblastoma, nonsmall cell lung cancer, gastric cancer, and hepatocellular carcinoma [13, 47, 48]. The gene discussed is ESM1; the disease is lung cancer.